171 results
Page 2 of 9
S-4
EX-10.23
b75kw 8o6toglr94w8k
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.27
oaqmqag
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.24
ly2 1x5il
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.31
8tw7g r8rg308glf3b3
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-10.2
n3ia2qpi40m qetyb2
30 Mar 23
Business combination disclosure
8:51am
425
EX-10.5
la7eymlj7cn
30 Mar 23
Business combination disclosure
8:51am
425
EX-10.4
a2k8jjpzyuv37sz6bh
30 Mar 23
Business combination disclosure
8:51am
425
EX-10.3
orwarran
30 Mar 23
Business combination disclosure
8:51am
425
EX-10.1
0f35fu dn
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-10.3
55si8op6996kdetcks
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.4
a87pij134wjlf pa44xr
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.1
84lrvcy0a201lr4ui
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.2
v4g8pos
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.5
6j01u
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.1
l0gpq a26z
16 Feb 23
Termination of a Material Definitive Agreement
4:56pm
8-K
EX-10.1
vt5 1yzjdfqyq3
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
8-K
EX-10.1
3gqd10aembkti
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-10.1
1t6cs8 lpdrp3d7aguhy
18 Mar 22
Entry into a Material Definitive Agreement
5:14pm